EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Only the strong survive: therapeutic selective pressure drives medulloblastoma leptomeningeal metastasis

Francis Y He, Adrienne Boire iD

Molecular Oncology · 2025

DOI: 10.1002/1878-0261.70125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Francis Y He und 1 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Program, Graduate School of Biomedical Science, Weill Cornell Medicine, New York, USA. Hauptthemen laut MEDLINE: Medulloblastoma, Meningeal Neoplasms, Cerebellar Neoplasms. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Medulloblastoma (MB) is the most common malignant tumor in the central nervous system in childhood and regularly metastasizes to the leptomeninges following radiation therapy. Using patient‐derived medulloblastoma models and genetically engineered mouse models, Nör et al. observed enhanced inflammation and infiltration of myeloid cells within the brain following irradiation. The authors identified inflammatory cytokines and the resulting breakdown of blood–brain barriers as the main culprits of MB leptomeningeal metastasis. This study demonstrated that targeting inflammation through the use of dexamethasone effectively reduced systemic inflammatory cytokines and the resulting radiation‐induced leptomeningeal metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedulloblastomaMeningeal NeoplasmsCerebellar NeoplasmsAnimalsHumansMiceDexamethasoneCytokines

Stichwörter der Autor:innen

leptomeningeal metastasismedulloblastomaradiation therapy

Substanzen

DexamethasoneCytokines

Autor:innen und Institutionen

  • Neuroscience Program, Graduate School of Biomedical Science, Weill Cornell Medicine, New York, USA.
  • Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, USA.

ORCID-Profile: Adrienne Boire

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

He, F. Y., & Boire, A. (2025). Only the strong survive: therapeutic selective pressure drives medulloblastoma leptomeningeal metastasis. Molecular Oncology. https://doi.org/10.1002/1878-0261.70125

Vancouver

He FY, Boire A. Only the strong survive: therapeutic selective pressure drives medulloblastoma leptomeningeal metastasis. Molecular Oncology. 2025. doi:10.1002/1878-0261.70125

BibTeX
@article{He2025,
  author = {He, Francis Y and Boire, Adrienne},
  title = {Only the strong survive: therapeutic selective pressure drives medulloblastoma leptomeningeal metastasis},
  journal = {Molecular Oncology},
  year = {2025},
  doi = {10.1002/1878-0261.70125}
}
Kostenlos starten →